- Home
- AAPG vs INTR Comparison
AAPG vs INTR Comparison
Compare AAPG & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAPG
- INTR
- Stock Information
- Founded
- AAPG 2009
- INTR 1994
- Country
- AAPG China
- INTR Brazil
- Employees
- AAPG N/A
- INTR N/A
- Industry
- AAPG Biotechnology: Pharmaceutical Preparations
- INTR
- Sector
- AAPG Health Care
- INTR
- Exchange
- AAPG Nasdaq
- INTR Nasdaq
- Market Cap
- AAPG 3.6B
- INTR 3.3B
- IPO Year
- AAPG 2025
- INTR N/A
- Fundamental
- Price
- AAPG $40.54
- INTR $8.91
- Analyst Decision
- AAPG Buy
- INTR Hold
- Analyst Count
- AAPG 1
- INTR 2
- Target Price
- AAPG N/A
- INTR $5.55
- AVG Volume (30 Days)
- AAPG 11.7K
- INTR 2.0M
- Earning Date
- AAPG 11-06-2025
- INTR 08-06-2025
- Dividend Yield
- AAPG N/A
- INTR 0.33%
- EPS Growth
- AAPG N/A
- INTR 69.31
- EPS
- AAPG N/A
- INTR 0.47
- Revenue
- AAPG $54,524,554.00
- INTR $974,787,476.00
- Revenue This Year
- AAPG N/A
- INTR $82.28
- Revenue Next Year
- AAPG $387.72
- INTR $21.46
- P/E Ratio
- AAPG N/A
- INTR $19.27
- Revenue Growth
- AAPG N/A
- INTR 38.56
- 52 Week Low
- AAPG $16.50
- INTR $3.88
- 52 Week High
- AAPG $48.45
- INTR $9.07
- Technical
- Relative Strength Index (RSI)
- AAPG N/A
- INTR 69.13
- Support Level
- AAPG N/A
- INTR $8.17
- Resistance Level
- AAPG N/A
- INTR $8.79
- Average True Range (ATR)
- AAPG 0.00
- INTR 0.21
- MACD
- AAPG 0.00
- INTR 0.02
- Stochastic Oscillator
- AAPG 0.00
- INTR 83.96
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop. It generates maximum revenue from the Banking & Spending segment which comprises a wide range of banking products and services, such as checking accounts, cards, deposits, loans and advances, and other services, which are available to the clients by means of Inter's mobile application.